Patients 3 ways to make 2024 the year of the patient Clinical research is never just about the next year; it's always about the next several years.
Digital Retaining the human element of AI within pharma and healthca... Artificial intelligence (AI) has been the word of 2023, but aside from the promises, what are the realities of its practical implementation in the life sciences setting?
Partner Content Partner Content The ryze-elluminate integration to maximise automation in cl... The ryze-elluminate integration
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
